Patent · US Expired

Suspension comprising oxcarbazepine

US8119148B2 · kind B2 · utility

2Cited by

19References

39Claims

0Family size

Assignee

Novartis Pharmaceuticals Corporation · US

Inventors

Juergen Sigg · Soest, DE
Michael Billington · Riehen, CH

Key dates

Filing date	Dec 19, 2000
Grant date	Feb 21, 2012
Priority date	—
Expiry date	Dec 19, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a pharmaceutical composition in the form of a suspension comprising oxcarbazepine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.